HHS Secretary Robert F. Kennedy Jr. announced eight new members to the U.S. Preventive Services Task Force on Thursday, completing the 16-member volunteer panel after months of turnover and political conflict around its leadership. The USPSTF makes recommendations on preventive health services including screenings, counseling and medications intended to improve population health.
Those appointments carry market significance because the Affordable Care Act gave the task force added authority in 2010 by requiring payers to fully cover preventive services that receive A or B ratings from the panel. Changes in who sits on the USPSTF can therefore affect not just public-health guidance, but coverage obligations tied to preventive care.
The reset at the task force
Seth Corey, a pediatric hematologist-oncologist at Cleveland Clinic, will serve as the task force’s new chair. The other appointees named were pediatrician Patrick Hunter, cardiologist Ronald Karlsberg, preventive-cardiology professor Venkatesh Murthy, health economist Stephen Parente, family physician Goldie Stands-Over-Bull, gastroenterologist Louis Wilson and radiologist Dennis Wulfeck.
The announcement follows a prolonged reshaping of the panel. Nearly four months ago, Kennedy dismissed vice chairs John Wong and Esa Davis, prompting outcry from healthcare groups. The panel had also been thinned by five members’ terms expiring without replacement, and the previous chair had departed on his own. MedCity News also reported that Kennedy had been clashing with the panel, with reports emerging last year that he wanted to dismiss all of the USPSTF’s members because their views were considered too "woke."
Why the appointments matter
Kennedy said the move would strengthen the task force’s scientific rigor and that the new appointments will "ensure it asks hard questions, follows the evidence wherever it leads and maintains the highest standards of scientific integrity."
The American Medical Association responded more cautiously, saying the additions represent "a significant departure" from the panel’s traditional membership. The group added that maintaining a strong primary care voice must remain central to the USPSTF’s work and that its recommendations must continue to be based on a transparent, rigorous, independent scientific process informed by physicians who deliver preventive care.
The signal here is structural: when a panel’s recommendations are directly linked to payer coverage, leadership changes become a health-policy lever with downstream effects for clinicians, insurers and companies tied to preventive screening and treatment pathways.
